share_log

JS環球生活:2024 中期報告

JS GLOBAL LIFE: 2024 INTERIM REPORT

HKEX ·  Sep 25 04:41

Summary by Moomoo AI

JS環球生活有限公司(「本公司」)於2024年6月30日止六個月的中期簡明綜合財務資料顯示,公司持續經營業務的總收入為743.0百萬美元,同比增加29.5%。毛利為245.8百萬美元,同比增加15.2%。毛利率為33.1%,相比去年同期的37.2%減少4.1個百分點。報告期間持續經營業務的溢利同比減少35.9%至約29.6百萬美元。母公司擁有人應佔溢利同比減少約37.0%至約21.8百萬美元。報告期間的EBITDA同比下降43.0%至約41.7百萬美元及報告期間的經調整EBITDA同比減少64.4%至約28.1百萬美元。報告期間的經調整純利同比減少69.2%至約16.0百萬美元。於報告期間,本...展開全部
JS環球生活有限公司(「本公司」)於2024年6月30日止六個月的中期簡明綜合財務資料顯示,公司持續經營業務的總收入為743.0百萬美元,同比增加29.5%。毛利為245.8百萬美元,同比增加15.2%。毛利率為33.1%,相比去年同期的37.2%減少4.1個百分點。報告期間持續經營業務的溢利同比減少35.9%至約29.6百萬美元。母公司擁有人應佔溢利同比減少約37.0%至約21.8百萬美元。報告期間的EBITDA同比下降43.0%至約41.7百萬美元及報告期間的經調整EBITDA同比減少64.4%至約28.1百萬美元。報告期間的經調整純利同比減少69.2%至約16.0百萬美元。於報告期間,本集團收購深圳甲殼蟲智能有限公司68.4517%股權,收購的購買代價以現金於收購日期前支付2,868,000美元,而14,674,000美元則於收購日期支付。自收購日期起,深圳甲殼蟲智能有限公司為本集團貢獻收入約5,617,000美元及淨虧損1,553,000美元。倘合併於期初進行,則本集團於期內的持續經營業務收入及溢利將分別為747,438,000美元及27,065,000美元。
js global life limited ("the Company")'s summarized interim financial information for the six months ended 30 June 2024 shows that the total revenue from the continuing business operations was $743.0 million, an increase of 29.5% year-on-year. The gross profit was $245.8 million, an increase of 15.2% year-on-year. The gross margin was 33.1%, a decrease of 4.1 percentage points compared to 37.2% in the same period last year. The profit from continuing operations for the reporting period decreased by 35.9% year-on-year to approximately $29.6 million. The profit attributable to owners of the parent company decreased by approximately 37.0% to approximately $21.8 million year-on-year. EBITDA for the reporting period decreased by 43.0% year-on-year to approximately $41.7 million, and adjusted EBITDA for the reporting period decreased by...Show More
js global life limited ("the Company")'s summarized interim financial information for the six months ended 30 June 2024 shows that the total revenue from the continuing business operations was $743.0 million, an increase of 29.5% year-on-year. The gross profit was $245.8 million, an increase of 15.2% year-on-year. The gross margin was 33.1%, a decrease of 4.1 percentage points compared to 37.2% in the same period last year. The profit from continuing operations for the reporting period decreased by 35.9% year-on-year to approximately $29.6 million. The profit attributable to owners of the parent company decreased by approximately 37.0% to approximately $21.8 million year-on-year. EBITDA for the reporting period decreased by 43.0% year-on-year to approximately $41.7 million, and adjusted EBITDA for the reporting period decreased by 64.4% year-on-year to approximately $28.1 million. Adjusted net profit for the reporting period decreased by 69.2% year-on-year to approximately $16.0 million. During the reporting period, the Group acquired 68.4517% equity interest in Shenzhen Cockroach Asia Vets Limited. The consideration paid for the acquisition was $2,868,000 in cash before the acquisition date, and $14,674,000 was paid on the acquisition date. Since the acquisition date, Shenzhen Cockroach Asia Vets Limited has contributed revenue of approximately $5,617,000 and a net loss of $1,553,000 to the Group. If the merger had occurred at the beginning of the period, the Group's revenue and profit from continuing business operations for the period would have been $747,438,000 and $27,065,000 respectively.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more